Hamza Celik
Critic · DISC type CHamza Celik is the Director of Hematology-Oncology Drug Discovery at Incyte, where he leads multi-disciplinary teams on small molecule drug discovery programs from initial identification to IND. His expertise is rooted in his academic research at Washington University and a Ph. D. from CNRS, complemented by a recent PocketMBA.
Outside of his direct research, Hamza is a supportive leader who actively mentors scientists and champions rising talent in the field. He shows a keen interest in the intersection of science and business, following publications like the Harvard Business Review and encouraging recruitment for his growing teams.
Unique fact: Hamzas past research included developing strategies to use CRISPR technology as a "finely-honed molecular scalpel" to edit the epigenome.
Read the full overview →How Hamza shows up
They like to do things independently and don’t look for support from others. It is very likely that they will negotiate pricing or other important terms. Unless the value is proven by data, they are unlikely to value fancy features.
Topics Hamza cares about
Work history
Media appearances
DISC profile (public)
Calculativeness (C)
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Other Incyte Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.